VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,207,609 | -82.7% | 235,604 | -54.6% | 0.01% | -82.1% |
| Q2 2023 | $12,727,440 | +35.7% | 518,852 | +28.8% | 0.03% | +21.7% |
| Q1 2023 | $9,376,600 | +26.3% | 402,948 | +4.6% | 0.02% | 0.0% |
| Q3 2022 | $7,426,000 | +2745.2% | 385,146 | +3657.9% | 0.02% | +2200.0% |
| Q2 2022 | $261,000 | -97.1% | 10,249 | -95.3% | 0.00% | -96.8% |
| Q4 2021 | $9,157,000 | +684.7% | 218,710 | +715.7% | 0.03% | +520.0% |
| Q3 2021 | $1,167,000 | +27.5% | 26,811 | +38.6% | 0.01% | +25.0% |
| Q2 2021 | $915,000 | -71.0% | 19,343 | -79.0% | 0.00% | -89.2% |
| Q1 2020 | $3,152,000 | – | 91,977 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |